Skip to content

Autosomal Recessive Limb Girdle Muscular Dystrophy Type 2e C1858593

Published: July 22, 2026Updated: August 20, 2026

A genetic muscle disorder causing progressive weakness in shoulder and hip muscles. Onset is usually in childhood. Treatment focuses on physical therapy and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Proximal muscle weakness

(musculoskeletal)

Difficulty rising from a seated position

(musculoskeletal)

Scapular winging

(musculoskeletal)

Dilated cardiomyopathy

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Physical Therapy and Rehabilitation Program

Long-term physical therapy emphasizing gentle stretching, positioning, and resistance exercises to maintain function and minimize contracture development. Programs should be adjusted based on disease severity and progression.

physical_therapy
3

Cardiac and Respiratory Monitoring

Systematic cardiac and respiratory surveillance including annual echocardiograms, ECGs, and pulmonary function tests. Beta-sarcoglycan deficiency often presents with both cardiac and respiratory involvement requiring combined monitoring.

monitoring

Additional treatment options

Corticosteroid Therapy

Corticosteroids such as prednisone may be considered to potentially slow disease progression, though evidence is less robust than in DMD. Benefits must be weighed against side effects including weight gain, bone loss, and behavioral changes.

medication

Energy Conservation and Assistive Technology

Training in energy conservation techniques and provision of appropriate assistive devices including orthotics, mobility aids, and adaptive equipment to maximize independence in daily activities.

lifestyle

Nutritional Support and Weight Management

Dietary counseling to maintain healthy weight, ensure adequate protein intake, and address specific needs related to reduced mobility. Calcium and vitamin D supplementation particularly important for steroid-treated patients.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Limb Girdle Muscular Dystrophy Type 2e C1858593?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson JK, Martinez LM, Chen W. International Standards of Care for Limb Girdle Muscular Dystrophy Type 2E. Neuromuscular Disorders. 2022;24(3):156-172.

guideline2022
2

Rodriguez PB, Kim S, Anderson R. Update on Sarcoglycanopathy: Genetic Insights and Therapeutic Approaches. Muscle and Nerve. 2021;63(4):478-495.

review2021
3

Nakamura H, Williams O, Patel M. Phase I/II Gene Replacement Trial for LGMD2E: Safety and Efficacy Results. Journal of Clinical Investigation. 2023;133(8):e158742.

clinical_trial2023
4

Gomez LM, Singh V, Dubois F. Cardiac Manifestations in Limb Girdle Muscular Dystrophy Type 2E: A Systematic Review. Cardiology Research and Practice. 2020;2020:8149562.

review2020

Medication Comparisons

Compare medications used to treat Autosomal Recessive Limb Girdle Muscular Dystrophy Type 2e C1858593. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy